Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA ABBOTT INDIA DISHMAN PHARMA/
ABBOTT INDIA
 
P/E (TTM) x 30.0 48.7 61.6% View Chart
P/BV x 3.3 15.5 21.7% View Chart
Dividend Yield % 0.7 1.4 48.8%  

Financials

 DISHMAN PHARMA   ABBOTT INDIA
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ABBOTT INDIA
Mar-22
DISHMAN PHARMA/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs37423,902 1.6%   
Low Rs12914,553 0.9%   
Sales per share (Unadj.) Rs197.02,315.0 8.5%  
Earnings per share (Unadj.) Rs21.2375.9 5.6%  
Cash flow per share (Unadj.) Rs34.7407.0 8.5%  
Dividends per share (Unadj.) Rs2.00275.00 0.7%  
Avg Dividend yield %0.81.4 55.6%  
Book value per share (Unadj.) Rs179.91,306.2 13.8%  
Shares outstanding (eoy) m80.7021.25 379.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.38.3 15.4%   
Avg P/E ratio x11.951.2 23.2%  
P/CF ratio (eoy) x7.347.2 15.3%  
Price / Book Value ratio x1.414.7 9.5%  
Dividend payout %9.473.2 12.9%   
Avg Mkt Cap Rs m20,307408,573 5.0%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3555,795 92.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89849,193 32.3%  
Other income Rs m265774 34.3%   
Total revenues Rs m16,16349,967 32.3%   
Gross profit Rs m4,10310,875 37.7%  
Depreciation Rs m1,091661 165.0%   
Interest Rs m944191 494.5%   
Profit before tax Rs m2,33410,797 21.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6242,810 22.2%   
Profit after tax Rs m1,7107,987 21.4%  
Gross profit margin %25.822.1 116.7%  
Effective tax rate %26.726.0 102.7%   
Net profit margin %10.816.2 66.2%  
BALANCE SHEET DATA
Current assets Rs m11,01838,530 28.6%   
Current liabilities Rs m9,51712,032 79.1%   
Net working cap to sales %9.453.9 17.5%  
Current ratio x1.23.2 36.2%  
Inventory Days Days576 931.9%  
Debtors Days Days32 163.6%  
Net fixed assets Rs m18,7873,541 530.5%   
Share capital Rs m161213 76.0%   
"Free" reserves Rs m14,35427,544 52.1%   
Net worth Rs m14,51627,756 52.3%   
Long term debt Rs m4,1890-   
Total assets Rs m29,80542,072 70.8%  
Interest coverage x3.557.5 6.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.51.2 45.6%   
Return on assets %8.919.4 45.8%  
Return on equity %11.828.8 40.9%  
Return on capital %17.539.6 44.3%  
Exports to sales %24.90.7 3,495.7%   
Imports to sales %3.710.2 36.5%   
Exports (fob) Rs m3,956350 1,129.7%   
Imports (cif) Rs m5945,034 11.8%   
Fx inflow Rs m4,952415 1,194.6%   
Fx outflow Rs m6975,117 13.6%   
Net fx Rs m4,255-4,702 -90.5%   
CASH FLOW
From Operations Rs m2,7869,477 29.4%  
From Investments Rs m-1,529-3,958 38.6%  
From Financial Activity Rs m-941-6,374 14.8%  
Net Cashflow Rs m317-856 -37.0%  

Share Holding

Indian Promoters % 61.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 23.0 8.1 285.1%  
FIIs % 12.0 0.2 5,985.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 25.0 154.3%  
Shareholders   52,291 83,526 62.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    PIRAMAL ENTERPRISES    


More on Dishman Pharma vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Abbott India Share Price Performance

Period Dishman Pharma Abbott India S&P BSE HEALTHCARE
1-Day 2.87% -1.69% -0.10%
1-Month -2.45% 3.01% -1.99%
1-Year 96.38% 6.11% -5.62%
3-Year CAGR 50.28% 16.96% 20.96%
5-Year CAGR 41.17% 29.54% 11.47%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Abbott India paid Rs 275.0, and its dividend payout ratio stood at 73.2%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Snaps 8-Day Winning Streak to End 416 Points Lower| Nifty Today Ends Below 18,700 | Auto and IT Stocks Drags(Closing)

After opening the day on a negative note, Indian share markets continued their momentum and ended the day 0.7% lower.